Abstract:Background: To utilize machine learning for identifying treatment response genes in diabetic foot ulcers (DFU). Methods: Transcriptome data from patients with DFU were collected and subjected to comprehensive analysis. Initially, differential expression analysis was conducted to identify genes with significant changes in expression levels between DFU patients and healthy controls. Following this, enrichment analyses were performed to uncover biological pathways and processes associated with these differentially expressed genes. Machine learning algorithms, including feature selection and classification techniques, were then applied to the data to pinpoint key genes that play crucial roles in the pathogenesis of DFU. An independent transcriptome dataset was used to validate the key genes identified in our study. Further analysis of single-cell datasets was conducted to investigate changes in key genes at the single-cell level. Results: Through this integrated approach, SCUBE1 and RNF103-CHMP3 were identified as key genes significantly associated with DFU. SCUBE1 was found to be involved in immune regulation, playing a role in the body's response to inflammation and infection, which are common in DFU. RNF103-CHMP3 was linked to extracellular interactions, suggesting its involvement in cellular communication and tissue repair mechanisms essential for wound healing. The reliability of our analysis results was confirmed in the independent transcriptome dataset. Additionally, the expression of SCUBE1 and RNF103-CHMP3 was examined in single-cell transcriptome data, showing that these genes were significantly downregulated in the cured DFU patient group, particularly in NK cells and macrophages. Conclusion: The identification of SCUBE1 and RNF103-CHMP3 as potential biomarkers for DFU marks a significant step forward in understanding the molecular basis of the disease. These genes offer new directions for both diagnosis and treatment, with the potential for developing targeted therapies that could enhance patient outcomes. This study underscores the value of integrating computational methods with biological data to uncover novel insights into complex diseases like DFU. Future research should focus on validating these findings in larger cohorts and exploring the therapeutic potential of targeting SCUBE1 and RNF103-CHMP3 in clinical settings.

Use of Serum Protein Measurements as Biomarkers That Can Predict the Outcome of Diabetic Foot Ulceration

Lower Serum Branched-Chain Amino Acid Catabolic Intermediates Are Predictive Signatures Specific to Patients with Diabetic Foot.

Extensive serum biomarker analysis before and after treatment in healing of diabetic foot ulcers using a cytokine antibody array

Combined with dynamic serum proteomics and clinical follow-up to screen the serum proteins to promote the healing of diabetic foot ulcer

Integrated Skin Transcriptomics and Serum Multiplex Assays Reveal Novel Mechanisms of Wound Healing in Diabetic Foot Ulcers

Biomarker Prediction Of Postoperative Healing Of Diabetic Foot Ulcers A Retrospective Observational Study Of Serum Albumin

Tandem Mass Tag-Based Serum Proteomic Profiling Revealed Diabetic Foot Ulcer Pathogenesis and Potential Therapeutic Targets

Identification of phase angle and Triglyceride-Glucose index as biomarkers for prediction and management of diabetic foot disease

Gene expression levels of inflammatory mediators in diabetic foot ulcer patients

A study of Apolipoprotein A1(ApoA1) And Interleukin-10(IL-10) In Diabetes With Foot Ulcers

An improved clinical and genetics-based prediction model for diabetic foot ulcer healing

The impact of inflammatory biomarkers on amputation rates in patients with diabetic foot ulcers

Integrated Bioinformatics-Based Identification of Potential Diagnostic Biomarkers Associated with Diabetic Foot Ulcer Development

Machine learning-driven discovery of novel therapeutic targets in diabetic foot ulcers

The risk factors in diabetic foot ulcers and predictive value of prognosis of wound tissue vascular endothelium growth factor

On diabetic foot ulcer knowledge gaps, innovation, evaluation, prediction markers, and clinical needs

Unravelling the Molecular Footprints of Diabetic Foot Ulcers: In Silico Discovery of Key Protein and MicroRNA Signatures

Level of 25-Hydroxyvitamin D and Vitamin D Receptor in Diabetic Foot Ulcer and Factor Associated with Diabetic Foot Ulcers

Improving Dietary Intake of Essential Nutrients Can Ameliorate Inflammation in Patients with Diabetic Foot Ulcers

Wound fluid sampling methods and analysis of cytokine mRNA expression in ulcers from patients with diabetes mellitus

Transcriptomic identification of genes expressed in invasive S. aureus diabetic foot ulcer infection